Savara, Inc. (SVRA)
5.30
-0.02
(-0.38%)
USD |
NASDAQ |
Sep 11, 16:00
5.305
0.00 (0.00%)
After-Hours: 20:00
Savara Enterprise Value : 945.99M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 945.99M |
| September 10, 2026 | 950.10M |
| September 09, 2026 | 969.61M |
| September 08, 2026 | 993.23M |
| September 04, 2026 | 960.37M |
| September 03, 2026 | 960.37M |
| September 02, 2026 | 978.85M |
| September 01, 2026 | 956.26M |
| August 31, 2026 | 964.48M |
| August 28, 2026 | 937.77M |
| August 27, 2026 | 985.02M |
| August 26, 2026 | 1.010B |
| August 25, 2026 | 1.008B |
| August 24, 2026 | 999.39M |
| August 21, 2026 | 1.006B |
| August 20, 2026 | 985.02M |
| August 19, 2026 | 1.004B |
| August 18, 2026 | 960.37M |
| August 17, 2026 | 960.37M |
| August 14, 2026 | 962.42M |
| August 13, 2026 | 939.83M |
| August 12, 2026 | 1.028B |
| August 11, 2026 | 1.001B |
| August 10, 2026 | 1.034B |
| August 07, 2026 | 1.055B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.047B |
| August 05, 2026 | 989.12M |
| August 04, 2026 | 968.58M |
| August 03, 2026 | 952.15M |
| July 31, 2026 | 978.85M |
| July 30, 2026 | 995.29M |
| July 29, 2026 | 941.88M |
| July 28, 2026 | 952.15M |
| July 27, 2026 | 972.69M |
| July 24, 2026 | 989.12M |
| July 23, 2026 | 1.038B |
| July 22, 2026 | 1.018B |
| July 21, 2026 | 1.057B |
| July 20, 2026 | 985.02M |
| July 17, 2026 | 991.18M |
| July 16, 2026 | 991.18M |
| July 15, 2026 | 1.051B |
| July 14, 2026 | 1.026B |
| July 13, 2026 | 1.036B |
| July 10, 2026 | 1.096B |
| July 09, 2026 | 1.149B |
| July 08, 2026 | 1.168B |
| July 07, 2026 | 1.133B |
| July 06, 2026 | 1.131B |
| July 02, 2026 | 1.135B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Gilead Sciences, Inc. | 199.64B |
| Insmed, Inc. | 27.83B |
| United Therapeutics Corp. | 18.55B |
| Vertex Pharmaceuticals, Inc. | 124.70B |
| ACADIA Pharmaceuticals, Inc. | 3.908B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -40.23M |
| Total Expenses (Quarterly) | 40.23M |
| EPS Diluted (Quarterly) | -0.1587 |
| Earnings Yield | -10.88% |
| Normalized Earnings Yield | -10.88 |